- $460.13m
- $440.99m
- $148.14m
- 89
- 24
- 81
- 71
Annual income statement for TSS, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 45.1 | 27.4 | 30.6 | 54.4 | 148 |
| Cost of Revenue | |||||
| Gross Profit | 6.8 | 6.36 | 8.98 | 11 | 22.4 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 44.6 | 28.2 | 29.7 | 52.6 | 140 |
| Operating Profit | 0.496 | -0.831 | 0.914 | 1.75 | 8.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.129 | -1.23 | -0.017 | 0.134 | 6.13 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.079 | -1.3 | -0.073 | 0.074 | 5.98 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.079 | -1.3 | -0.073 | 0.074 | 5.98 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.079 | -1.3 | -0.073 | 0.074 | 5.98 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.024 | -0.071 | -0.004 | 0.003 | 0.238 |